Carbon footprint mapping is an important tool for the pharma industry to identify environmental impact and make informed decisions. With the help of carbon footprint mapping, pharma companies can measure and track their CO2 emissions, energy consumption, water usage and other environmental metrics. This will enable them to better understand their environmental performance and identify areas for improvement.
Moreover, carbon footprint mapping also helps pharma companies to set realistic sustainability goals in order to reduce their carbon footprint. By analysing the data from the carbon footprint mapping process, they can develop strategies that will help them reduce emissions while maintaining a competitive edge in the industry.
This webinar will explore:
What are Scope 1, 2 and 3 emissions?
Why monitor company emissions?
Methods for mapping Scope 1, 2 and 3 emissions.
What makes best practice? Pitfalls and poor practice to be avoided.
Beyond carbon – what else should be monitored?



